Edition:
United States

Terumo Corp (4543.T)

4543.T on Tokyo Stock Exchange

3,925JPY
24 Mar 2017
Change (% chg)

¥25 (+0.64%)
Prev Close
¥3,900
Open
¥3,905
Day's High
¥3,930
Day's Low
¥3,885
Volume
1,386,700
Avg. Vol
1,314,817
52-wk High
¥4,840
52-wk Low
¥3,820

4543.T

Chart for 4543.T

About

TERUMO CORPORATION is manufacturer of medical supplies. The Hospital Products segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The Cardiac and Vascular... (more)

Overall

Beta: 0.75
Market Cap(Mil.): ¥1,490,560.00
Shares Outstanding(Mil.): 379.76
Dividend: 21.00
Yield (%): 1.02

Financials

  4543.T Industry Sector
P/E (TTM): 39.25 34.18 29.94
EPS (TTM): 99.99 -- --
ROI: 4.62 12.74 13.01
ROE: 6.89 14.79 14.16

BRIEF-R&I affirms Terumo's rating at "AA-" and announces stable outlook – R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" – R&I

Mar 15 2017

BRIEF-Terumo buys back 11 mln shares for 44.22 bln yen

* Says it completed share repurchase plan disclosed on Feb. 9, with a result of 11 million shares repurchased for 44.22 billion yen

Feb 09 2017

BRIEF-Terumo names Takahito Mimura as chairman and Shinjiro Sato as president

Feb 9 Terumo Corp: * Says the co names Takahito Mimura as chairman of the board * Says the co names Shinjiro Sato as president and CEO * Says effective on April 1 Source text in Japanese:https://goo.gl/mpOLIG Further company coverage: (Beijing Headline News)

Feb 09 2017

BRIEF-Terumo to buy back 11 mln shares for 50 bln yen via ToSTNeT-3

* Says the co plans to buy back up to 11 million shares(3.03 percent stake) for no more than 50 billion yen via ToSTNeT-3 on Feb. 10

Feb 09 2017

BRIEF-Olympus, Terumo to dissolve capital alliance

* Olympus says to sell its entire 2.48 pct stake in Terumo back to Terumo

Feb 09 2017

Exclusive: EU regulators seen clearing $25 billion Abbott, St Jude deal: source

EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories' $25 billion bid for rival St. Jude Medical Inc , a person familiar with the matter said on Tuesday.

Nov 15 2016

BRIEF-Terumo's first-half operating profit likely rose 2 pct to roughly 40 bln yen - Nikkei

* Terumo's first-half operating profit likely rose 2 pct on the year to roughly 40 billion yen ($388 million) - Nikkei

Nov 04 2016

Abbott offers EU concessions over $25 billion St. Jude deal

BRUSSELS Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc , according to the European Commision.

Nov 03 2016

Abbott offers EU concessions over $25 bln St Jude deal

BRUSSELS, Nov 3 Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc, according to the European Commision.

Nov 03 2016

Terumo shares up 2 percent on news it will buy U.S. firms' medical devices

TOKYO Shares of Terumo Corp rose on Wednesday morning after two U.S. companies said they will sell some of their medical devices to the Japanese medical equipment maker.

Oct 18 2016

More From Around the Web

Earnings vs. Estimates